Open access
4,969
Views
21
CrossRef citations to date
0
Altmetric
Report
HX008: a humanized PD-1 blocking antibody with potent antitumor activity and superior pharmacologic properties
Jibin Zhanga School of Pharmaceutical Science, Wuhan University, Wuhan, China;b Department of Research & Development, HanX Biopharmaceuticals, Inc, Wuhan, ChinaView further author information
, Ying Huangb Department of Research & Development, HanX Biopharmaceuticals, Inc, Wuhan, ChinaView further author information
, Gan Xib Department of Research & Development, HanX Biopharmaceuticals, Inc, Wuhan, ChinaView further author information
& Faming Zhanga School of Pharmaceutical Science, Wuhan University, Wuhan, China;b Department of Research & Development, HanX Biopharmaceuticals, Inc, Wuhan, ChinaCorrespondence[email protected]
View further author information
View further author information
Article: 1724751
|
Received 02 Nov 2019, Accepted 16 Jan 2020, Published online: 27 Feb 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.